We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Dr
Johanna
Taylor
Jo.Taylor@york.ac.uk
Dr
Najma
Siddiqi
najma.siddiqi@york.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
Diabetes mellitusMood [affective] disordersSchizophrenia, schizotypal and delusional disorders
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
People with a severe mental illness (SMI), e.g. schizophrenia or bipolar disorder, are almost three times more likely to have diabetes, and experience poorer health and healthcare than the general population. Diabetes has a major psychosocial impact, causing distress, poor quality of life and reduced capacity for self-management. People with SMI have additional psychological and social difficulties that are likely to increase their risk of diabetes distress and poor quality of life. However, very little is known about the impact of diabetes in this population. This study will explore the psychological and social impact of having diabetes alongside SMI and experience of diabetes healthcare. The aim is to increase understanding of how to improve diabetes care, including diabetes self-management for this vulnerable population. We will survey people with SMI and diabetes, their carers and healthcare professionals to examine the psychosocial impact of diabetes in SMI including diabetes distress, quality of life, and factors affecting diabetes self-management. Participants will be recruited through general practices and mental health services. We will compare findings with data from DAWN2, a global study of diabetes in the general population. We will also test whether questions to measure diabetes distress and psychosocial impact are appropriate for people with SMI. Multi-stakeholder workshops will be used to discuss findings and identify opportunities to increase support for diabetes management. This study will provide insights on how diabetes can be managed more effectively for people with SMI. Study findings will be disseminated through our established research, clinical and service user networks to increase knowledge among clinicians and service providers, who sometimes make assumptions about why people with SMI experience poor diabetes outcomes (e.g. attributing blame to lifestyle and life choices). People with SMI and diabetes should experience better care, and improved physical and mental health outcomes as a result.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Cross-sectional;
You can take part if:
You may not be able to take part if:
• Patients: • Under 18 years of age • No diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder and manic episodes, or non-organic psychoses • No diagnosis of diabetes • Women with diabetes only diagnosed in pregnancy • Living in a hospital setting • Do not have capacity to provide informed consent to participate in the study Carers / supporters: • Family members or friends of participants who are not identified by patient participants as providing care or support • Under 18 years of age • Do not have capacity to provide informed consent to participate in the study Healthcare staff: • Healthcare staff who do not support patients with either severe mental illness OR diabetes. There are no other exclusion criteria for this sample.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Dr
Najma
Siddiqi
najma.siddiqi@york.ac.uk
Dr
Johanna
Taylor
Jo.Taylor@york.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by University of York and funded by THE BRITISH DIABETIC ASSOCIATION .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 32962
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
